Skip to content
Home
What is Alzheimer’s Disease?
Stages of Alzheimer’s Disease
Mild: Early-Stage
Moderate: Middle-Stage
Severe: Late-stage
Early-Onset AD
Causes of Alzheimer’s Disease
Symptoms of Alzheimer’s Disease
Pseudobulbar Affect in Alzheimer’s Disease
Diagnosis of Alzheimer’s Disease
Alzheimer’s Disease Statistics
Living with Alzheimer’s Disease
Alzheimer’s Disease Treatment
Approved Treatments for Alzheimer’s Disease
Aricept (Donepezil)
Exelon (Rivastigmine)
Namenda (Memantine)
Namzaric (Donepezil and Memantine)
Nuedexta
Oligomannate
Razadyne (Galantamine)
Experimental Treatments for Alzheimer’s Disease
Anti-Agitation Medication
AVP-786
AXS-05
Brexpiprazole
Prazosin
Neurotransmitter Modifying Medication
DB105 (ORM-12741)
Nuplazid (Pimavanserin)
PXT864
Riluzole
SUVN-502
Non-Drug Treatments
Deep Brain Stimulation of the Fornix
Repetitive Transcranial Magnetic Stimulation (rTMS)
Treatments That Target Amyloid-Beta
ABvac40
Aducanumab
Allopregnanolone
ALZT-OP1
BAN2401
CAD106
Crenezumab
Donanemab (LY3002813)
Elayta (CT1812)
Gantenerumab
Lu AF20513
PMN310
PMN330
PMN350
PQ912
Saracatinib
Solanezumab
UB-311
Treatments That Target Tau
AADvac1
ABBV-8E12
ACI-35
LMTX
RO7105705
Zagotenemab (Formerly LY3303560)
Treatments with Other Modes of Action
Anavex 2-73
Azeliragon
Carvedilol
Curcumin
Leukine (Sargramostim)
Liraglutide
Nicotinamide
Nasal Insulin
Piromelatine
Sumifilam (PTI-125)
Resveratrol
S-equol
T3D-959
Thiethylperazine
Telmisartan
TPI 287
Xanamem
Treatments No Longer Under Development
Atabecestat (Formerly JNJ-54861911)
CNP520 (Umibecestat)
Elenbecestat
Gemfibrozil
Intepirdine
Lanabecestat
Lumateperone (ITI-007)
LY3202626
Thalidomide
Columns
Dementia Days
Treading Dark Waters
Login
COVID-19 Info
COVID-19 Updates
Search for:
Nothing Found
It seems we can’t find what you’re looking for. Perhaps searching can help.
Search for:
